![]() Shanghai Medicilon Shanghai Medicilon (美迪西生物医药) is a contract research organization (CRO) that provides biopharmaceutical preclinical research and development solutions. | ||||
Founding Date | Founding Date 2004 | Founding Date 2009 | Founding Date 2015 | Founding Date 2005 |
Type | Type Public | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Shanghai, CN HQ | Locations Norwood, US HQ | Locations Hyderabad, IN HQ Hamburg, DE Turkapally, IN Visakhapatnam, IN Visakhapatnam, IN Visakhapatnam, IN Visakhapatnam, IN see more | |
Employees | Employees 2,600 | Employees 14183% increase | Employees 2,5061% increase | Employees 5,75359% increase |
Valuation ($) | Valuation ($) 664.4 m | Valuation ($) 195.1 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) ¥1.2b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₹67.2b (FY, 2026) |
Cost of goods | Cost of goods ¥961.2m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods ₹27.6b (FY, 2026) |
Gross profit | Gross profit ¥200.3m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit ₹40.7b (FY, 2026) |
Net income | Net income (¥167.8m) (FY, 2025) | Net income ($78.5m) (FY, 2025) | Net income N/A | Net income ₹8.9b (FY, 2026) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 12.7m | Total funding raised N/A | Total funding raised $ 90m |

Corbus Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company.
View company
Alfasigma is a pharmaceutical company providing prescription and over-the-counter drugs.
View company